$TMCI· SEC filing ·

TMCI Preliminary Q1 Revenue $47.1M, Cash $51.9M, Updates 2026 Guidance to $202M-$212M, CEO John T. Treace

Treace Medical Concepts, Inc. Common Stock · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · Now $3.60

Post-detection moves

1h
1d
3d
7d
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS